The Latest Cardiac and Vascular News
WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular®, a developer of next generation angioplasty balloons using proprietary serration technology, announced the completion of $11.87 million in Series B funding. The round was led by two strategic investors including one that participated in the Series A financing. Additional participants included Balestier Investments, Ben Franklin Technology […]
FRANKLIN LAKES, N.J., July 12, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that support the company’s 2020 Sustainability Goals. BD’s sustainability strategy is driven by its purpose – advancing the world of health – and focuses on […]
ABBOTT PARK, Ill., July 12, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced it received approval from the U.S. Food and Drug Administration (FDA) for a next-generation version of its leading MitraClip® heart valve repair device used to repair a leaky mitral valve without open-heart surgery. The transcatheter clip-based therapy, now on a third generation […]
IRVINE, Calif., July 12, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended June 30, 2018 after the market closes on Thursday, July 26, 2018, and will host a conference call at 5:00 p.m. […]
MARLBOROUGH, Mass., July 11, 2018 /PRNewswire/ — CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for atrial fibrillation (AF), today announced the commercial launch of its HeartLight Endoscopic Ablation System in Japan. The commercial launch will be managed in conjunction with its distribution partner JapanLifeline Co., Ltd. (JLL). The commercial launch follows […]
(GLOBE NEWSWIRE via COMTEX) –DUBLIN – July 12, 2018 – Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) labeling expansion for the Medtronic SelectSecure(TM) MRI SureScan(TM) Model 3830 cardiac pacing lead to include stimulation of the bundle of His. It is the only pacing lead on the market […]
REDWOOD CITY, Calif., July 12, 2018 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has entered into a securities purchase agreement with certain institutional investors providing for the purchase and sale of 2,166,180 shares of common stock […]
EDEN PRAIRIE, Minn., July 12, 2018 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ:CHFS), today announces it has entered into the German market by expanding a relationship with HSC-Medical, GmbH, a business solutions resource based in Germany. HSC-Medical will serve as a fulfillment house and logistical support for CHF Solutions, while the […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release its second quarter 2018 financial results on Wednesday, August 1, 2018. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Wednesday, […]
July 11, 2018 11:45 AM Eastern Daylight Time PARIS–(BUSINESS WIRE)–Regulatory News: STENTYS (Paris:STNT) (FR0010949404 — STNT), a French group specialized in medical technologies for interventional cardiology, today reports its consolidated revenues and cash position at June 30, 2018. Christophe Lottin, Chief Executive Officer of STENTYS, comments: “The second quarter of 2018 notably […]
Notifications